Healthscope, Australia’s second-largest private hospital operator, has received 10 non-binding indicative offers as part of a sale process set to conclude within eight to ten weeks, CEO Tino La Spina announced Monday.

The announcement comes after the company was placed into receivership amid mounting financial pressure.

Creditors are seeking to recover an estimated A$1.6 billion ($1.04 billion) in debt, prompting the move to sell the business. Despite the financial turmoil, La Spina emphasized that hospital operations will continue without disruption.

“There will be a change of ownership. Receivers have been appointed to sell off Healthscope hospital assets,” La Spina told reporters at a press conference. “But from the point of view of doctors, nurses, staff, and patients, there's nothing to worry about — it's just business as usual.”

La Spina noted significant buyer interest in acquiring the company as a single, integrated business, raising hopes for a stable transition.

Healthscope operates 37 hospitals nationwide, and the uncertainty surrounding its financial future has drawn concern from both patients and public officials.

At a separate briefing, Health Minister Mark Butler said he had spoken directly with the CEO to seek assurances that patient care will remain unaffected. “I sought an assurance from him that the thousands of Australians who right now have a birth plan or knee reconstruction booked can be confident their procedure will go ahead as planned,” Butler said. “I received that assurance... and I will hold the company and the receivers to that commitment.”

Butler also made it clear that no taxpayer-funded bailout would be provided to rescue the private operator.

The receivership follows a decision by Healthscope’s lenders, who took control from its private equity owner Brookfield. According to La Spina, the “core issues” behind the collapse were excessive secured debt and high rental costs.

To ensure operational continuity during the sale process, Commonwealth Bank of Australia has issued a new A$100 million funding package to support Healthscope under the guidance of receivers McGrathNicol, the company confirmed.

The coming weeks will be critical in determining the fate of one of Australia’s largest private healthcare providers, but for now, officials and company leadership insist that patient care remains secure and uninterrupted.

Copied